Total Payments
$635.97
2024 Payments
$244.64
Companies
9
Transactions
19
Medicare Patients
2,239
Medicare Billing
$265,447
Payment Breakdown by Category
Food & Beverage$635.97 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $635.97 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $216.69 | 4 | $0 (2024) |
| Abbott Laboratories | $162.24 | 2 | $0 (2024) |
| Novo Nordisk Inc | $106.53 | 5 | $0 (2018) |
| Lilly USA, LLC | $56.23 | 3 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $24.77 | 1 | $0 (2022) |
| Amgen Inc. | $20.94 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $16.76 | 1 | $0 (2018) |
| TherapeuticsMD, Inc. | $16.46 | 1 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $15.35 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $244.64 | 2 | Abbott Laboratories ($150.00) |
| 2023 | $27.51 | 1 | Lilly USA, LLC ($27.51) |
| 2022 | $45.71 | 2 | IDORSIA PHARMACEUTICALS US INC ($24.77) |
| 2020 | $18.05 | 1 | Boston Scientific Corporation ($18.05) |
| 2019 | $120.81 | 3 | Boston Scientific Corporation ($92.11) |
| 2018 | $179.25 | 10 | Novo Nordisk Inc ($106.53) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $94.64 | General |
| 05/29/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Vascular | ||||||
| 09/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Diabetes | ||||||
| 11/07/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: INSOMNIA | ||||||
| 08/31/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Inflammation | ||||||
| 01/21/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: STRUCTURAL HEART | ||||||
| 12/09/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/18/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 02/18/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $92.11 | General |
| Category: STRUCTURAL HEART | ||||||
| 12/06/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Diabetes | ||||||
| 09/25/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Diabetes | ||||||
| 09/11/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: STRUCTURAL HEART | ||||||
| 08/31/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 07/17/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Diabetes | ||||||
| 07/10/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 05/15/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 05/01/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: AED | ||||||
| 04/16/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/13/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 630 | 1,037 | $101,398 | $72,388 |
| 2022 | 17 | 626 | 1,099 | $107,434 | $78,706 |
| 2021 | 14 | 508 | 878 | $86,559 | $66,824 |
| 2020 | 11 | 475 | 702 | $61,619 | $47,529 |
Total Patients
2,239
Total Services
3,716
Medicare Billing
$265,447
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 316 | $42,214 | $28,484 | 67.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 146 | $10,855 | $8,510 | 78.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $9,097 | $8,424 | 92.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 43 | $8,908 | $5,897 | 66.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 70 | $7,474 | $5,860 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 107 | $10,064 | $5,692 | 56.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 29 | 40 | $4,377 | $3,432 | 78.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $4,702 | $3,044 | 64.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 61 | 61 | $1,147 | $1,080 | 94.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 58 | 58 | $1,090 | $1,027 | 94.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 63 | 68 | $1,036 | $688.08 | 66.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 21 | $302.19 | $207.10 | 68.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 13 | $130.00 | $44.33 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 302 | $40,344 | $28,818 | 71.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 197 | $14,647 | $11,070 | 75.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 157 | $14,767 | $9,277 | 62.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 54 | 54 | $7,332 | $7,046 | 96.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 80 | $8,542 | $6,555 | 76.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 37 | $7,665 | $5,809 | 75.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 44 | $4,814 | $3,593 | 74.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $2,961 | $1,955 | 66.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $2,116 | $1,532 | 72.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,394 | $891.93 | 64.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 38 | 38 | $714.40 | $699.85 | 98.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 38 | 38 | $714.40 | $687.71 | 96.3% |
About Dr. Thomas Zolkos, M.D
Dr. Thomas Zolkos, M.D is a Internal Medicine healthcare provider based in Parrish, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174593289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Zolkos, M.D has received a total of $635.97 in payments from pharmaceutical and medical device companies, with $244.64 received in 2024. These payments were reported across 19 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($635.97).
As a Medicare-enrolled provider, Zolkos has provided services to 2,239 Medicare beneficiaries, totaling 3,716 services with total Medicare billing of $265,447. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Parrish, FL
- Active Since 01/23/2006
- Last Updated 05/19/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174593289
Products in Payments
- MITRACLIP (Device) $150.00
- WATCHMAN (Device) $122.05
- Victoza (Drug) $67.53
- Ozempic (Drug) $39.00
- TRULICITY (Drug) $28.72
- MOUNJARO (Drug) $27.51
- QUVIVIQ (Drug) $24.77
- Otezla (Drug) $20.94
- DIFICID (Drug) $16.76
- IMVEXXY (Drug) $16.46
- TROKENDI XR (Drug) $15.35
- Proclaim Family of SCS IPGs (Device) $12.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parrish
Rozina Idrees, M.d, M.D
Internal Medicine — Payments: $609.43
Internal Medicine $609.43
Mohammad Sheikh, M.d, M.D
Internal Medicine — Payments: $423.11
Internal Medicine $423.11
Klaudio Alla, Md, MD
Internal Medicine — Payments: $104.57
Internal Medicine $104.57
Dr. Mark Nickels, M.d, M.D
Internal Medicine — Payments: $61.30
Internal Medicine $61.30
Dr. Shayne Moyles, D.o, D.O
Internal Medicine
Internal Medicine
Joseph Lindley, D.o, D.O
Internal Medicine
Internal Medicine